Charles Greene, MD
Otolaryngology · Jacksonville, FLNPI 1306876651
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.9%. Reporting peaked in 2019 at $6,697 and has fallen 63.9% since, to $2,414 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $81.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$5K
- Aerin Medical Inc.$4K
- Intersect ENT, Inc.$4K
- Medical Device Business Services, Inc.$2K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$958
- plus $3K from 19 others
What the payments were for
- Consulting fees$1,4748%
- Speaking & faculty fees$3,00016%
- Travel & lodging$5,22027%
- Food & beverage$8,84446%
- Education$340%
- Gifts$40%
- Other$4642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 98 | $4,559 |
| Aerin Medical Inc. | 30 | $4,063 |
| Intersect ENT, Inc. | 18 | $3,574 |
| Medical Device Business Services, Inc. | 6 | $1,766 |
| Sanofi | 11 | $1,398 |
| Regeneron Healthcare Solutions, Inc. | 19 | $958 |
| Stryker | 6 | $462 |
| Photonicare Inc | 2 | $381 |
| Novartis | 6 | $343 |
| GSK | 11 | $309 |
| Johnson & Johnson(3 entities) | 3 | $263 |
| Inspire Medical Systems, Inc. | 2 | $165 |
| Medtronic | 2 | $137 |
| Novo Nordisk | 1 | $115 |
| Baxter Healthcare | 1 | $105 |
| Acclarent, Inc | 2 | $96 |
| Smith+Nephew | 1 | $78 |
| Amgen | 2 | $56 |
| Alk-abello, Inc | 3 | $42 |
| Linvatec Corporation | 2 | $41 |
| Merck | 2 | $34 |
| Hikma Pharmaceuticals USA | 2 | $33 |
| Galderma Laboratories, L.p. | 2 | $33 |
| Kaleo, Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$3,708
- PROPEL$3,069
- SINUVA$2,797
- Vivaer RF Stylus$1,884
- DUPIXENT$1,591
- VivAer$910
- RhinAer$910
- OtoSight Middle Ear Scope$359
- Inspire$147
- CLARIFIX CRYOTHERAPY DEVICE$125
- INVOKANA$125
- XOLAIR$125
- NUCALA$123
- ENTELLUS - XPRESS ENT DILATION SYSTEM$122
- SPIROX - LATERA$122
- Tresiba$115
- VIVAER STYLUS$113
- RHINAER STYLUS$113
- LINX Reflux Management System$113
- Hillrom - Spot Vision Screener$105
How this compares
$19,040 in reported general payments places this provider in the 90th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 29 | $17,277 |
| Fluticasone Propionate | 1,284 | $16,795 |
| Fluocinolone Acetonide Oil | 151 | $5,897 |
| Ipratropium Bromide | 189 | $5,499 |
| Azelastine Hcl | 154 | $5,413 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 28 | $2,995 |
| Pantoprazole Sodium | 428 | $2,648 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $505 |
| Omeprazole | 69 | $463 |
| Acetic Acid | 21 | $372 |
| Methylprednisolone | 53 | $287 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $210 |
| Famotidine | 23 | $186 |
| Dexamethasone | 12 | $160 |
| Amoxicillin | 40 | $154 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $4,559 | $17,27729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 586 otolaryngology providers in Florida.
Other otolaryngology in Jacksonville
- Samip PatelJacksonville$38K
- Iman NaseriJacksonville$24K
- Alexander FaragJacksonville$15K
- Angela DonaldsonJacksonville$15K
- Jeffrey JanusJacksonville$11K
- Jeffrey RadabaughJacksonville$10K
- William BolgerJacksonville$9K
- Faisal AhmadJacksonville$9K
- Cecelia DamaskOrlando$707K
- Ralph TufanoSarasota$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.